Drug
TP-271
TP-271 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
NCT03450187
completedphase_1
A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
NCT02724085
completedphase_1
A Phase 1 Safety and PK Study of IV TP-271
NCT03234738
completedphase_1
A Phase 1 TP-271 Oral PK Single Ascending Dose Study
NCT03024034
Clinical Trials (4)
Showing 4 of 4 trials
NCT03450187Phase 1
A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study
NCT02724085Phase 1
A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271
NCT03234738Phase 1
A Phase 1 Safety and PK Study of IV TP-271
NCT03024034Phase 1
A Phase 1 TP-271 Oral PK Single Ascending Dose Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4